7European society of hypertension-European Society of cardiology Guidelines committee.2003 European Society of Hypertension-European Society of cardi-ology guidelines for the management of arterial hy-portension[J].Hypertans,2003,21(6):1011.
3Conlin PR,Spence JD, Williams B, et al. Angiotensin II antagonists for hypertension: are there differences in efficacy ? Am J Hypertens,2000, 13(4 pt 1) : 418.
4Plum J, Bunten B, Nemeth R, et al. Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension. J Am Soc Nephrol, 1998,9(12) :2223.
5Fogari R,Zoppi A, Poletti L, et al. Sexual activity in hypertensive men treated with valsartan or carvedilol : a crossover study. Am J Hypertens,2001,14(1) :27.
6Peters R, Beckett N, Fagard R, et al. Increased pulse pressure linked todementia :further results from the Hypertension in the Very Elderly Tri- al-HYVET [J ]. J Hypertens,2013,31 (9) : 1868 - 1875.
7Pella D. Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 rag:results of the FALCO FORTE Programme [ J ]. High Blood Press Cardiovasc Prey, 2011,18 (3) :107 - 113.
8Neglia D,Fommei E, Varela-Carver A,et al. Perindopril and indapam- ide reverse coronary microvascular remodelling and improve flow in ar- terial hypertension [J ]. J Hypertens,2011,29 (2) :364 - 372.
9Felicio J S, De Souza A C, Kohlmann N, et al.Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes[J].Cardiovasc Diabetol, 2010, 9(4): 1-6.
